BD8522931
4-Amino-N-(2-diethylaminoethyl)benzamide , 97% , 51-06-9
CAS NO.：51-06-9
Empirical Formula: C13H21N3O
Molecular Weight: 235.33
MDL number: MFCD00066880
EINECS: 200-078-8
| Pack Size | Price | Stock | Quantity |
| 250mg | RMB61.60 | In Stock |
|
| 1g | RMB156.80 | In Stock |
|
| 5g | RMB725.60 | In Stock |
|
| 25g | RMB3152.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 47°C |
| Boiling point: | 377.72°C (rough estimate) |
| Density | 1.060 |
| refractive index | 1.5700 (estimate) |
| storage temp. | Keep in dark place,Inert atmosphere,Room temperature |
| solubility | Chloroform (Slightly), Ethyl Acetate (Slightly) |
| form | Solid |
| pka | pKa 9.24±0.10 (Uncertain) |
| color | Off-White to Light Brown |
Description and Uses
Procainamide and its analogs were employed by Dr Claude Beck in a series of cardiac surgeries during the early 1930s. The compound was used to alleviate arrhythmias that present during the procedures, and was selected for its favorable tissue absorption properties. Procainamide’s central amide provides it protection from inactivating esterase action and allows oral administration of the compound. Procainamide was approved for use in the United States in 1950.
Procainamide is used in the management of atrial and ventricular tachydysrhythmias.
Safety
| RIDADR | 2811 |
| HazardClass | 6.1 |
| PackingGroup | Ⅲ |
| Hazardous Substances Data | 51-06-9(Hazardous Substances Data) |
